Hall SE - Search Results

1

Molecular design and structure--activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664.

Das J, Kimball SD, Hall SE, Han WC, Iwanowicz E, Lin J, Moquin RV, Reid JA, Sack JS, Malley MF, Chang CY, Chong S, Wang-Iverson DB, Roberts DG, Seiler SM, Schumacher WA, Ogletree ML. Das J, et al. Among authors: hall se. Bioorg Med Chem Lett. 2002 Jan 7;12(1):45-9. doi: 10.1016/s0960-894x(01)00667-9. Bioorg Med Chem Lett. 2002. PMID: 11738570

2

9,11-epoxy-9-homoprosta-5-enoic acid analogues as thromboxane A2 receptor antagonists.

Das J, Hall SE, Nakane M, Haslanger MF, Reid JA, Garber D, Truc VC, Harris DN, Hedberg A, Ogletree ML. Das J, et al. Among authors: hall se. J Med Chem. 1990 Jun;33(6):1741-8. doi: 10.1021/jm00168a032. J Med Chem. 1990. PMID: 2140414

3

9,11-Epoxy-9-homo-14-thiaprost-5-enoic acid derivatives: potent thromboxane A2 antagonists.

Hall SE, Han WC, Harris DN, Hedberg A, Ogletree ML. Hall SE, et al. J Med Chem. 1989 May;32(5):974-84. doi: 10.1021/jm00125a009. J Med Chem. 1989. PMID: 2523485

4

Interphenylene 7-oxabicyclo[2.2.1]heptane thromboxane A2 antagonists. Semicarbazone omega-chains.

Misra RN, Brown BR, Han WC, Harris DN, Hedberg A, Webb ML, Hall SE. Misra RN, et al. Among authors: hall se. J Med Chem. 1991 Sep;34(9):2882-91. doi: 10.1021/jm00113a030. J Med Chem. 1991. PMID: 1910091

5

9,11-Epoxy-9-homo-14-oxaprosta-5-enoic acid derivatives. Novel inhibitors of fatty acid cyclooxygenase.

Hall SE, Han WC, Haslanger MF, Harris DN, Ogletree ML. Hall SE, et al. J Med Chem. 1986 Nov;29(11):2335-47. doi: 10.1021/jm00161a032. J Med Chem. 1986. PMID: 3097316

6

Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonists.

Misra RN, Brown BR, Sher PM, Patel MM, Hall SE, Han WC, Barrish JC, Kocy O, Harris DN, Goldenberg HJ, et al. Misra RN, et al. Among authors: hall se. J Med Chem. 1993 May 14;36(10):1401-17. doi: 10.1021/jm00062a013. J Med Chem. 1993. PMID: 8496908

7

Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human platelets.

Hedberg A, Hall SE, Ogletree ML, Harris DN, Liu EC. Hedberg A, et al. Among authors: hall se. J Pharmacol Exp Ther. 1988 Jun;245(3):786-92. J Pharmacol Exp Ther. 1988. PMID: 2968449

8

Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.

Harris DN, Michel IM, Goldenberg HJ, Hartl KS, Allen GT, Steinbacher TE, Schumacher WA, Han WC, Hall SE, Floyd DM, et al. Harris DN, et al. Among authors: hall se. J Pharmacol Exp Ther. 1992 Apr;261(1):131-7. J Pharmacol Exp Ther. 1992. PMID: 1532833

9

Inhibition of prostaglandin biosynthesis by SQ 28,852, a 7-oxabicyclo[2.2.1]heptane analog.

Harris DN, Phillips MB, Michel IM, Goldenberg HJ, Steinbacher TE, Ogletree ML, Hall SE. Harris DN, et al. Among authors: hall se. Prostaglandins. 1986 Apr;31(4):651-67. doi: 10.1016/0090-6980(86)90172-3. Prostaglandins. 1986. PMID: 3088677

10

Thromboxane A2 receptor antagonists.

Hall SE. Hall SE. Med Res Rev. 1991 Sep;11(5):503-79. doi: 10.1002/med.2610110504. Med Res Rev. 1991. PMID: 1834898 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters